Management of Diabetic Ketoacidosis
Tóm tắt
Diabetic ketoacidosis is an all too frequent and sometimes preventable complication of Type I diabetes mellitus, responsible for significant morbidity and mortality within the diabetic population. Precipitating diseases account for the majority of deaths occurring in patients admitted in diabetic ketoacidosis, but some deaths are still attributable to ketoacidosis alone, despite recent advances in therapy and management. Recognition of the ketoacidotic state is paramount to optimal therapy, and often hinges on the diagnostic acumen of the physician. Since 20 to 30% of patients presenting in diabetic ketoacidosis do so as the initial manifestation of their previously undiagnosed disease, physicians must maintain a high level of suspicion for this condition. Understanding the pathogenetic mechanisms leading to and prevailing in diabetic ketoacidosis will allow physicians to intervene in a rational manner, approaching therapy with specific end-points in mind: (a) restoration of optimal volume status; (b) reversal of acidosis; (c) reduction of serum glucose levels; (d) replacement of specific electrolytes in a timely manner; (e) institution of appropriate therapy for any precipitating cause; and, (f) careful monitoring of the patient’s biochemical, physical and mental parameters to allow adjustment in therapy as necessary. The mainstay of treatment for diabetic ketoacidosis is appropriate fluid and insulin therapy. Low-dose intravenous infusion is now the accepted mode of insulin delivery for patients with this condition. Potassium replacement is almost always necessary, often requiring massive amounts of this ion due to the total body depletion seen with the development of ketoacidosis. Controversy still surrounds routine use of phosphate in diabetic ketoacidosis but replacement may be needed if serum levels fall toward the lower limits of normal values, to avoid the potential adverse effects of phosphate depletion. Administration of bicarbonate is also controversial and should be reserved for patients whose pH is less than 7.0 to 7.1 and then it should be added to intravenous fluids, not given as an intravenous bolus. Efforts toward preventing diabetic ketoacidosis should be of prime importance to physician and patient alike. Preventive measures should include patient education about diabetes mellitus, precipitating factors of diabetic ketoacidosis, signs and symptoms of early metabolic decompensation, rational insulin therapy during minor illness and appropriate timing of physician contact to help avoid this serious and sometimes fatal complication of diabetes mellitus.
Tài liệu tham khảo
Adrogue HJ, Lederer ED, Suki WN, Eknoyan G. Determinants of plasma potassium levels in diabetic ketoacidosis. Medicine 65: 163–172, 1986
Assal J, Aoki TT, Manzano FM, Kozak GP. Metabolic effects of sodium bicarbonate in management of diabetic ketoacidosis. Diabetes 23: 405–411, 1974
Axelrod L. Diabetic emergencies and the Loch Ness monster. Intensive Care Medicine 13: 1–3, 1987
Bachmann W, Walter H, Lotz N, Mehnert H. Efficiency of human insulin (recombinant DNA) in the treatment of diabetic ketoacidosis and severe nonketoacidotic hyperglycemia. Diabetes Care 5: 161–164, 1982
Beigelman PM. Potassium in severe diabetic ketoacidosis. American Journal of Medicine 54: 419–420, 1973
Bergenstal RM. Diabetic ketoacidosis: how to treat and, when possible, prevent. Postgraduate Medicine 77: 151–161, 1985
Brogden RN, Heel RC. Human insulin. A review of its biological activity, pharmacokinetics and therapeutic use. Drugs 34: 350–371, 1987
Cryer PE, White NH, Santiago JV. The relevance of glucose counterregulatory systems to patients with insulin-dependent diabetes mellitus. Endocrine Reviews 7: 131–139, 1986
Dorin RI, Crapo LM. Hypokalemic respiratory arrest in diabetic ketoacidosis. Journal of the American Medical Association 257: 1517–1518, 1987
Ellemann K, Soerensen JN, Pedersen L, Edsberg B, Andersen OO. Epidemiology and treatment of diabetic ketoacidosis in a community population. Diabetes Care 7: 528–532, 1984
Faich GA, Fishbein HA, Ellis SE. The epidemiology of diabetic acidosis: a population-based study. American Journal of Epidemiology 117: 551–558, 1983
Fisher JN, Kitabchi AE. A randomized study of phosphate therapy in the treatment of diabetic ketoacidosis. Journal of Clinical Endocrinology and Metabolism 57: 177–180, 1983
Fort P, Waters SM, Lifshitz F. Low-dose insulin infusion in the treatment of diabetic ketoacidosis: bolus versus no bolus. Journal of Pediatrics 96: 36–40, 1980
Foster DW, McGarry JD. The metabolic derangements and treatment of diabetic ketoacidosis. New England Journal of Medicine 309: 159–169, 1983
Hale PJ, Crase J, Nattrass M. Metabolic effects of bicarbonate in the treatment of diabetic ketoacidosis. British Medical Journal 289: 1035–1038, 1984
Hammeke M, Bear R, Lee R, Goldstein M, Halperin M. Hyperchloremic metabolic acidosis in diabetes mellitus: a case report and discussion of the pathophysiologic mechanisms. Diabetes 27: 16–20, 1978
Hasselstrom L, Wimberley PD, Nielsen VG. Hypophosphatemia and acute respiratory failure in a diabetic patient. Intensive Care Medicine 12: 429–431, 1986
Hillman K. Fluid resuscitation in diabetic emergencies: a reappraisal. Intensive Care Medicine 13: 4–8, 1987
Johnson DD, Palumbo PJ, Chu CP. Diabetic ketoacidosis in a community-based population. Mayo Clinic Proceedings 55: 83–88, 1980
Kebler R, McDonald FD, Cadnapaphornchai P. Dynamic changes in serum phosphorus levels in diabetic ketoacidosis. American Journal of Medicine 79: 571–576, 1985
Keller U. Diabetic ketoacidosis: current views on pathogenesis and treatment. Diabetologia 29: 71–77, 1986
Keller U, Berger W. Prevention of hypophosphatemia by phosphate infusion during treatment of diabetic ketoacidosis and hyperosmolar coma. Diabetes 29: 87–95, 1980
Keller U, Berger W, Ritz R, Truog P. Course and prognosis of 86 episodes of diabetic coma: a five year experience with a uniform schedule of treatment. Diabetologia 11: 93–100, 1975
Kitabchi AE, Ayyagari V, Guerra SMO, et al. The efficacy of low-dose versus conventional therapy of insulin for treatment of diabetic ketoacidosis. Annals of Internal Medicine 84: 633–638, 1976
Kreisberg RA. Diabetic ketoacidosis: new concepts and trends in pathogenesis and treatment. Annals of Internal Medicine 88: 681–695, 1978
Lever E, Jaspan JB. Sodium bicarbonate therapy in severe diabetic ketoacidosis. American Journal of Medicine 75: 263–268, 1983
Levine SN, Loewenstein JE. Treatment of diabetic ketoacidosis. Archives of Internal Medicine 141: 713–715, 1981
Matz R. Cerebral oedema in diabetic ketoacidosis. Lancet 2: 689, 1987
McGarry JD, Foster DW. Ketogenesis and its regulation. American Journal of Medicine 61: 9–13, 1976
Narins RG, Cohen JL. Bicarbonate therapy for organic acidosis: the case for its continued use. Annals of Internal Medicine 106: 615–618, 1987
Oh MS, Carroll HJ, Goldstein DA, Fein IA. Hyperchloremic acidosis during recovery phase of DKA. Annals of Internal Medicine 89: 925–927, 1978
Pedersen O, Beck-Nielsen H. Insulin resistance and insulin-dependent diabetes mellitus. Diabetes Care 10: 516–523, 1987
Piters KM, Kumar D, Pei E, Bessman AN. Comparison of continuous and intermittent intravenous insulin therapies for diabetic ketoacidosis. Diabetologia 13: 317–321, 1977
Schade DS, Eaton RP. The controversy concerning counterre-gulatory hormone secretion: a hypothesis for the prevention of diabetic ketoacidosis? Diabetes 26: 596–598, 1977
Sheppard MC, Wright AD. The effect on mortality of low-dose insulin therapy for diabetic ketoacidosis. Diabetes Care 5: 111–113, 1982
Storms FEMG, Lutterman JA, Van’t Larr A. Comparison of efficacy of human and porcine insulin in treatment of diabetic ketoacidosis. Diabetes Care 10: 49–55, 1987
Unger RH, Foster DW. Diabetes mellitus. In Wilson & Foster (Eds) Williams textbook of endocrinology, 7th ed., pp. 1018–1080, WB Saunders Company, Philadelphia, 1985
Van der Meulen JA, Klip A, Grinstein S. Possible mechanism for cerebral oedema in diabetic ketoacidosis. Lancet 2: 306–308, 1987
Van Gaal LF, De Leeuw IH, Bekaert JL. Diabetic ketoacidosis-induced hyperkalemia: prevalence and possible origin. Intensive Care Medicine 12: 416–418, 1986
Wentworth SM. Ketoacidosis in the diabetic child: a metabolic emergency. Indiana Medicine 79: 416–418, 1986
Wilson HK, Keuer SP, Lea AS, Boyd AE, Eknoyan G. Phosphate therapy in diabetic ketoacidosis. Archives of Internal Medicine 142: 517–520, 1982